Similar Posts
AstraZeneca Pleads Guilty in Criminal Cancer Medicine Scheme
AstraZeneca Pleads Guilty in Criminal Cancer Medicine Scheme Sun, 22 Jun 2003 AstraZeneca agreed to a $355 million settlement in civil and criminal charges. Government prosecutors found that AstraZeneca reported to the government that the average wholesale price for a monthly dose of the prostate cancer drug, Zoladex, was about…
FDA Bad Faith – Daniel Troy’s pre-emption defense – Nat’l Law Journal
FDA Bad Faith – Daniel Troy’s pre-emption defense – Nat’l Law Journal Fri, 26 Mar 2004 Federal regulations require drug label warnings if there is “reasonable evidence” of a link between adverse effects and drug action. An article in the National Law Journal shows how s FDA’s chief counsel, Daniel…
InfoMail for February 21, 2002
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav February 21, 2002 Influencing Doctors: HowPharmaceutical Companies Use Enticement to "Educate" Doctors FYI Click on ABC TV’s web site below to see details of thisstory. http://abcnews.go.com/sections/primetime/2020/primetime_020221_detailmen_feature.html
Will the Cong Oversight / Investigations Committee Ask FDA the Tough Questions?
Will the Cong Oversight / Investigations Committee Ask FDA the Tough Questions? Wed, 22 Sep 2004 FDA’s complicity in concealing vital drug safety information that might have saved lives, is the subject of tomorrow’s hearing by the House subcommittee on Oversight and Investigations. Rayburn Office Bldg, room 2123 at 11:00….
Infomail Archive 2004
Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA to review “missing” drug company documents Dec 30: Family of Woman Killed by AIDS Drug Test Sues Doctors, Manufacturer Dec 30: Doctors, Too, Ask: Is This Drug Right? Dec 29: Bill would shield…
Unhealthy Ethics? The Price of NIH Credibility_ Editorials: WashPost / Los Angeles Times
Unhealthy Ethics? The Price of NIH Credibility_ Editorials: WashPost / Los Angeles Times Mon, 11 Apr 2005 Compare and contrast two editorials that focus on the new conflict of interest rules that were adopted by Dr. Elias Zerhouni, director of the National Institutes of Health, to rein in the corrupting…